Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-31 Sale |
2025-04-02 4:57 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
21,490 | $3.4659 | $74,482 | 3,355,280 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:32 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
4,595 | $3.1663 | $14,549 | 3,196,652 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-05 4:55 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
11,851 | $3.4687 | $41,108 | 3,201,247 (Direct) |
View |
| 2025-01-06 Sale |
2025-01-08 5:26 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
7,471 | $4.0466 | $30,232 | 3,213,098 (Direct) |
View |
| 2024-09-30 Sale |
2024-10-02 6:53 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
18,589 | $3.1962 | $59,414 | 3,220,569 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-07 4:05 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
4,135 | $18.73 | $77,440 | 3,023,002 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-11 5:10 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
5,841 | $16.33 | $95,372 | 2,900,470 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 8:21 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
100,000 | $31.86 | $3,186,336 | 3,067,617 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-10 7:20 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
5,968 | $36.3 | $216,629 | 2,892,617 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-06 Option Award |
2025-03-10 8:28 pm |
N/A 2035-03-05 |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
450,295 | $0 | 3,646,947 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-25 5:56 pm |
N/A 2025-02-26 |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
1,857 | $0 | 3,239,158 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-25 5:56 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
1,857 | $1.57 | 3,239,158 (Direct) |
View |
| 2024-09-12 Exercise |
2024-09-16 5:39 pm |
N/A 2025-02-26 |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
34,449 | $0 | 3,239,158 (Direct) |
View |
| 2024-09-12 Exercise |
2024-09-16 5:39 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
34,449 | $1.57 | 3,239,158 (Direct) |
View |
| 2024-04-16 Option Award |
2024-04-18 8:21 pm |
N/A 2034-04-15 |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
559,850 | $0 | 3,582,852 (Direct) |
View |
| 2024-02-26 Option Award |
2024-02-28 6:22 pm |
N/A 2034-02-25 |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
316,667 | $0 | 3,217,137 (Direct) |
View |
| 2023-11-16 Exercise |
2023-11-20 8:20 pm |
N/A 2025-02-26 |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
63,694 | $0 | 2,942,617 (Direct) |
View |
| 2023-11-16 Exercise |
2023-11-20 8:20 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
63,694 | $1.57 | 2,942,617 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-20 8:21 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
275,000 | $0 | 3,067,617 (Direct) |
View |
| 2022-05-05 Exercise |
2022-05-06 4:05 pm |
N/A 2023-02-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
334,520 | $0 | 2,898,585 (Direct) |
View |
| 2022-05-05 Exercise |
2022-05-06 4:05 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
334,520 | $0.37 | 2,898,585 (Direct) |
View |
| 2022-01-06 Conversion |
2022-01-10 8:32 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
4,870 | $0 | 2,901,565 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 8:32 pm |
N/A 2032-01-06 |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
412,500 | $0 | 2,901,565 (Direct) |
View |
Ownership |
2022-01-06 5:10 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
0 | $0 | 3,123,585 (Direct) |
View |